文献速递临床试验与 GCP

Huddinge在线延长暴露疗法(HOPE)治疗成人创伤后应激障碍的随机对照优效性试验研究方案

Study protocol of a randomized controlled superiority trial of Huddinge Online Prolonged Exposure therapy (HOPE) for adults with posttraumatic stress disorder.
PubMed 文献 · Trials · 2025-12-12

本研究为随机对照优效性试验,计划纳入286名成人创伤后应激障碍(PTSD)患者,随机接受10周Huddinge在线延长暴露疗法(HOPE)或主动对照(治疗师引导的互联网心理教育、放松与支持)。主要结局为临床医生用DSM-5PTSD量表(CAPS-5)评估的过去一个月PTSD症状严重程度,并评估多个次要结局。

要点

  • HOPE为数字治疗师引导的延长暴露方案,预试验显示初步有效性、可接受性与可行性。
  • 试验采用评估者盲法,比较HOPE与主动对照,不排除严重或复杂PTSD患者。
  • 主要结局为CAPS-5评估的过去一个月PTSD症状严重程度。

核心结论

  • 本研究将评估HOPE是否能有效减轻PTSD症状,并首次将数字延长暴露与主动对照比较且不排除严重或复杂PTSD患者。

研究设计与样本

  • 随机对照优效性试验,评估者设盲,计划纳入286名参与者,随机分配接受10周HOPE或主动对照(治疗师引导的互联网心理教育、放松与支持)。

主要发现

  • 预试验在精神科门诊环境中显示HOPE具有初步有效性、患者可接受性和可行性。
  • 主要结局为临床医生用CAPS-5评估的过去一个月PTSD症状严重程度。
  • 次要结局包括自评PTSD与复杂PTSD症状、抑郁、生活质量、成本效果、变化中介因素、脱落率和不良事件。

局限性

  • 试验执行中的潜在挑战包括参与者招募、保留、治疗依从性和治疗师保留。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive behavioral therapy (CBT) is considered a first-line treatment for posttraumatic stress disorder (PTSD) but is rarely available in regular care. Action is clearly needed to increase treatment availability. A possible solution to improve access to treatment would be the use of remotely delivered digital intervention. Internet-delivered CBT may also carry several other advantages compared to traditional psychological treatments (e.g., less therapist time per patient, bridging geographical distances between therapist and patient, and provision of a standardized intervention). In a pilot study conducted within a psychiatric outpatient setting, a digital therapist-guided prolonged exposure program (Huddinge Online Prolonged Exposure; HOPE) demonstrated preliminary effectiveness, patient acceptability, and feasibility. This project will build upon these findings and evaluate whether HOPE is effective in reducing PTSD symptoms. METHOD: The study is a randomized controlled superiority trial, with assessors masked to treatment allocation. Two hundred eighty-six participants will be randomly allocated to receive either 10 weeks of HOPE or an active control condition (therapist-guided internet-delivered psychoeducation, relaxation, and support). The primary outcome is the severity of symptoms of PTSD for the last month measured by the clinician-administered PTSD scale for DSM-5 (CAPS-5). Secondary outcomes include self-rated measures of symptoms of PTSD and complex PTSD, depression, quality of life, cost effectiveness, mediators of change, dropout rates, and adverse events. DISCUSSION: This study will be the first to compare digital prolonged exposure (HOPE) with an active control condition and not exclude patients with severe or complex PTSD. The strength of the study is that it is conducted in a clinical setting with wide eligibility criteria and the use of gold-standard measures to assess outcomes. Potential challenges in the execution of the trial include participant recruitment, retention, and adherence to treatment and therapist retention. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov; NCT05934162. Registered 6th July 2023. Open Science Framework https://osf.io/dsg9p/ . Registered 2nd September 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bragesjö M, Ivanov VZ, Andersson E, et al. Study protocol of a randomized controlled superiority trial of Huddinge Online Prolonged Exposure therapy (HOPE) for adults with posttraumatic stress disorder. Trials. 2025. PMID: 41388429. doi:10.1186/s13063-025-09361-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。